首页> 外文期刊>Clinical and experimental pharmacology & physiology >GSTA1*-69C/T and GSTO2*N142D as asthma- and allergy-related risk factors in Italian adult patients.
【24h】

GSTA1*-69C/T and GSTO2*N142D as asthma- and allergy-related risk factors in Italian adult patients.

机译:GSTA1 * -69C / T和GSTO2 * N142D是意大利成年患者中与哮喘和过敏相关的危险因素。

获取原文
获取原文并翻译 | 示例
           

摘要

1. Asthma and allergies are characterized by variable and subjective symptoms influenced by many genes, molecular mechanisms and environmental factors. The presence of inflammation and oxidative stress in the airways are important biochemical features of asthma and respiratory allergies. Glutathione S-transferase (GSTs) enzymes play an important role in cellular protection against inflammation, and functional genetic polymorphisms in GST genes show a significant association with asthma and allergy risk. Specifically, our previous study on asthmatic children highlighted GSTA1 and GSTO2 as novel susceptibility loci for asthma. 2. In the present study we focused our attention on GSTA1*-69C/T (rs3957357) and GSTO2*N142D (rs156697) polymorphisms to confirm our previous results in an independent adult study population and to clarify whether GSTA1 and GSTO2 gene polymorphisms are involved in a non-discriminative pathway towards asthma and respiratory allergy. 3. To accomplish this, we recruited 103 patients with respiratory allergies, 199 patients with asthma and 200 healthy controls. Genomic DNA extracted from buccal cells was screened for GSTA1*-69C/T and GSTO2*N142D single nucleotide polymorphisms. 4. The GSTA1*-69T and GSTO2*D142 variants are both associated with a significantly increased risk of asthma, whereas only GSTA1*-69C/T is significantly associated with allergies. These outcomes confirm the involvement of GSTO2 loci in asthma and suggest that GSTA1 is a common risk factor for asthma and allergies.
机译:1.哮喘和过敏的特征是受多种基因,分子机制和环境因素影响的可变和主观症状。气道中炎症和氧化应激的存在是哮喘和呼吸道过敏的重要生化特征。谷胱甘肽S-转移酶(GSTs)酶在细胞防御炎症中起重要作用,GST基因的功能性遗传多态性与哮喘和过敏风险显着相关。具体而言,我们先前对哮喘儿童的研究强调了GSTA1和GSTO2是哮喘的新型易感基因座。 2.在本研究中,我们将注意力集中在GSTA1 * -69C / T(rs3957357)和GSTO2 * N142D(rs156697)多态性上,以确认我们在独立的成年研究人群中的先前结果,并阐明是否涉及GSTA1和GSTO2基因多态性通过非歧视性途径治疗哮喘和呼吸道过敏。 3.为此,我们招募了103名呼吸道过敏患者,199名哮喘患者和200名健康对照者。筛选从颊细胞中提取的基因组DNA的GSTA1 * -69C / T和GSTO2 * N142D单核苷酸多态性。 4. GSTA1 * -69T和GSTO2 * D142变体均与哮喘风险显着增加相关,而仅GSTA1 * -69C / T与变态反应显着相关。这些结果证实了GSTO2基因位点参与哮喘,并提示GSTA1是哮喘和过敏的常见危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号